Touro Scholar
NYMC Faculty Publications

Faculty

10-1-2018

Regeneration of Neurotransmission Transcriptome in a Model of
Epileptic Encephalopathy after Antiinflammatory Treatment
Dumitru Iacobas
New York Medical College

Libor Velisek
New York Medical College
Author(s) ORCID Identifier:

0000-0001-9700-6537

Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_pubs
Part of the Nervous System Diseases Commons, and the Therapeutics Commons

Recommended Citation
Iacobas, D., & Velisek, L. (2018). Regeneration of Neurotransmission Transcriptome in a Model of Epileptic
Encephalopathy after Antiinflammatory Treatment. Neural Regeneration Research, 13 (10), 1715-1718.
https://doi.org/10.4103/1673-5374.238607

This Article is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for
inclusion in NYMC Faculty Publications by an authorized administrator of Touro Scholar. For more information,
please contact touro.scholar@touro.edu.

www.nrronline.org

NEURAL REGENERATION RESEARCH
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Abstract
Inflammation is an established etiopathogenesis factor of infantile spasms (IS), a therapy-resistant epileptic
syndrome of infancy. We investigated the IS-associated transcriptomic alterations of neurotransmission
in rat hypothalamic arcuate nucleus, how they are corrected by antiinflamatory treatments and whether
there are sex differences. IS was triggered by repeated intraperitoneal administration of N-methyl-D-aspartic acid following anti-inflammatory treatment (adreno-cortico-tropic-hormone (ACTH) or PMX53)
or normal saline vehicle to prenatally exposed to betamethasone young rats. We found that treatments
with both ACTH and PMX53 resulted in substantial recovery of the genomic fabrics of all types of synaptic
transmission altered by IS. While ACTH represents the first line of treatment for IS, the even higher efficiency of PMX53 (an antagonist of the complement C5a receptor) in restoring the normal transcriptome
was not expected. In addition to the childhood epilepsy, the recovery of the neurotransmission genomic
fabrics by PMX53 also gives hope for the autism spectrum disorders that share a high comorbidity with IS.
Our results revealed significant sex dichotomy in both IS-associated transcriptomic alterations (males more
affected) and in the efficiency of PMX53 anti-inflammatory treatment (better for males). Our data further
suggest that anti-inflammatory treatments correcting alterations in the inflammatory transcriptome may
become successful therapies for refractory epilepsies.
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Infantile spasms (IS; West syndrome; also epileptic spasms
during infancy first described by Dr. West in 1841) is a
severe epileptic encephalopathy of infancy. Etiology of IS
is quite complex and still not fully understood. Infantile
spasms are characterized by a triad of brief spastic seizures,
large amplitude asynchronous waves in the electroencephalography (EEG) recordings (hypsharrhythmia) and mental
deterioration underlying the seriousness of this condition.
Despite many years of investigation, the complete therapeutic solution for infantile spasms is far from available. Infantile spasms have also significant (up to 30%) comorbidity
with autism spectrum disorders (ASD). Because of this close
link, an effective treatment of IS covering common etiopathogenesis with ASD (such as neuroinflammation Ohja et
al, 2018) may contribute a treatment option for ASD as well.
Neuroinflammation has been established as one of the contributors to the pathophysiology of epilepsy (Aronica et al.,
2017). In both experimental animals and human patients,
transcriptomic analysis of different seizure types and epilepsies indicates significant changes in profiles of inflammatory
transcriptome as well as the transcriptome pertinent for
synaptic transmission (Laurén et al., 2010; Das et al., 2012).
Tuberous sclerosis (a condition resulting from TSC1 or
TSC2 gene mutations and characterized by occurrence of

neuroectodermal tubers) in humans is frequently associated
with infantile spasms that progress to other types of epilepsy. Patients with tuberous sclerosis have increases expression
of cell adhesion and inflammatory genes in the tubers plus
wide disarray of gene expression including genes involved
in synaptic transmission in the perituberal tissue (Boer et
al., 2010). Hence, we were interested in rodent models of
seizures and epilepsy, how transcriptomic profiles would
change as a function of seizure type, sex, and developmental
stage of the animal and whether treatments affecting inflammation can stabilize transcriptomic profiles of genes belonging to synaptic transmission.
In two previous papers (Iacobaş et al., 2013, 2018a) we analyzed the alterations of the gene expression profiles in the
hypothalamic arcuate nucleus of our rat model of IS (Velíšek
et al., 2007). These papers are part of our larger effort to understand the impact and commonalities of different forms
of epilepsy on the transcriptomes in various brain areas. In
addition to the arcuate nucleus in the IS model, we have also
profiled the CA1 (Friedman et al., 2013) and dentate gyrus
(Velíšková et al., 2015, 2017; Iacobaş et al., 2018b) regions
of the hippocampus involved in other models of seizures
and epilepsy. We have studied also the protective role of
estrogen against the seizure-induced neuronal injury
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in the hippocampus (Velíšková et al., 2015, 2017; Iacobaş et
al., 2018b). Data from the paraventricular nucleus and the
prefrontal cortex in the animal model of IS following ACTH
and PMX53 treatments are yet to be published.
We have had particular interest in how the spasms in our
model can affect the transcriptomic networks responsible for
the glutamatergic (denoted by GLU), GABAergic (GABA),
dopaminergic (DA), cholinergic (ACH) and serotonergic
(5HT) neurotransmission. Genes pertaining to each type of
neurotransmission were selected using Kyoto Encyclopedia
of Genes and Genomes developed by Kanehisa Laboratories
(http://www.genome.jp). While the impairment of neurotransmission can significantly contribute to the expression
of spasms, the neurotransmission recovery may become a
measure (marker) of treatment efficacy. This is particularly
important as current treatments of infantile spasms (adrenocorticotropic hormone-ACTH, corticosteroids and vigabatrin) are only partially effective (less than 55% efficacy after
one year), leaving many infants and their families without
hope for improvement in future.
In our two-hit IS rat model (Velíšek et al., 2007; Yum
et al., 2012), the animals were prenatally primed with two
doses of betamethasone delivered intraperitoneally to pregnant dams (control animals received saline). The spasms in
infant, betamethasone-primed, rats were postnatally triggered by repeated intraperitoneal administration of N-methyl-D-aspartic acid (NMDA). After the first bout of spasms
on postnatal day (P) 12, the rats were randomized into treatment groups or received vehicle (saline). Treatment delivery
and spasm trigger continued through P14 and P15, respectively. On P15, rats were anesthetized and brain regions of
interest were collected. Hypothalamic arcuate nucleus was
selected as the main region of interest because our previous
study indicated its prominent activation during experimental
spasms (Velíšek et al., 2007). Arcuate nuclei of both sexes
were profiled using Agilent two-color 4x44k gene expression microarrays and our optimized protocol (Iacobaş et al.,
2018a), with 4 biological replicas of each condition (20 males
and 20 females randomly distributed in 5 sex homogeneous
groups). Raw data and full description of the experimental
protocol are available as GSE81061 and GSE84585 at http://
www.ncbi.nlm.nih.gov/geo.
Since no neurotransmission gene was differently expressed between males and females in control rats (SNS; saline (S)-primed, no (N) induced spasms, postnatally injected
with saline (S)) we asked what transcriptomic feature might
explain the known behavioral sex differences. The response
came from our genomic fabric paradigm (Iacobaş, 2016)
that does not limit the characterization of the transcriptome
to the expression levels of individual genes but considers
also their expression control and coordination with expression of each other gene. By definition, the genomic fabric
of a functional pathway is the transcriptome associated to
the most interconnected and stably expressed gene network
responsible for that biological function. Thus, the pair-wise
relevance analysis (that takes into account the contributions
off all gene-pairs to the expression level, control and coordination to the neurotransmission transcriptomic landscape)
1716

has shown substantial differences between the two sexes
(Figure 8 in Iacobaş et al., 2013). Years of working with
animal models taught us that prenatal priming with betamethasone is not only essential for ACTH efficacy against
experimental spasms but it also increases the propensity of
rats to develop spasms after the NMDA trigger (Velíšek et
al., 2007). This pathophysiological finding can be explained
by the major alterations of the pair-wise relevant topology of
the genomic fabrics of the synaptic pathways in response to
the betamethasone priming.
Data in our randomized study of induced spasms clearly
showed that male pups displayed more spasms at the end of
the experiment compared to females. Indeed, the microarray analyses indicated that the transcriptomic effects of the
induced spasms on the neurotransmission are sex specific,
on average 3× larger in males than in females (Iacobaş et al.,
2018a). In addition to the percentage of the regulated genes,
we have evaluated the transcriptomic alterations using the
novel Weighted Pathway Regulation analysis that takes into
account all genes regardless of whether they were considered
as significantly regulated (according to arbitrarily introduced cut-offs). Further analysis determined that in males,
specifically GABA pathway transcriptome was significantly
impaired, while in females, the DA pathway was affected the
most by the spasms.
In the set of experiments with treatments, the betamethasone-primed (B) rats after the first trigger of spasms (Y)
were randomized into treatment groups treated either with
full molecule of rat ACTH (BYA group), PMX53 (BYP
group) or Saline (BYS group). ACTH (adrenocorticotropic
hormone) is the FDA-approved first line of treatment for
epileptic spasms in human infancy (Knupp et al., 2016).
PMX53, an antagonist of the C5a receptor, was suggested as
an alternative because of the positive results with this drug
in other models of epilepsy (Benson et al., 2015). Rationale
for using PMX53 was that neuroinflammation, including
that regulated via innate immune complement activation
through C5ar1, is significantly involved in both epilepsy and
ASD (Aronica et al., 2017; Ohja et al., 2018). Inhibition of
C5ar1 decreases production of tumor necrosis factor alpha
(TNFα), one of the key pro-inflammatory molecules responsible for microglial activation leading to neuronal damage
and hyperexcitability. Thus, by attenuation of neuroinflammation, PMX53 might improve excitatory/inhibitory balance, which is impaired in epilepsy (Benson et al., 2015) and
also in ASD. Since both infantile spasms and ASD have male
predominance (male:female ratio is approximately 1.5:1 in
infantile spasms and 3–4:1 in ASD), we evaluated males and
females separately and then compared the results.
After treatment (ACTH or PMX53) we noticed a significant suppression of spasms in males, but not as much
in females with respect to the corresponding betamethasone-primed pups with spasms, “treated” with saline only
(the BYS group). PMX53 had at least equal if not better
effects as ACTH on the suppression of spasms in males. It
should be noted here that we evaluated only those animals
entering the transcriptomic analysis (4 from each group)
hence the cohort size was small and could have contributed
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Figure 1 Experimental spasms alter the cholinergic transmission genes but both adreno-cortico-tropic-hormone (ACTH) and PMX53
treatments partially restore their normal expression.
In the set of experiments with treatments, the betamethasone-primed (B) rats after the first trigger of spasms (Y) were randomized into treatment
groups treated either with full molecule of rat ACTH (BYA group), PMX53 (BYP group) or Saline (BYS group). (A, B) (log2) expression levels of
cholinergic genes in BYS, BYA and BYP plotted against (log2) expression levels in non-spasm values (BNS). In these diagrams, the representative
points of the unaltered genes (same expression as in BNP) are located on the diagonal. Note that expression levels in BYA (blue dots) and BYP (green)
are significantly closer to those in BNS than expression levels in BYS (red) in both males (A) and females (B). (C) Average % square deviation of the
expression of cholinergic genes from the BNS in male and female rats. Note that males were more affected by the spasms (larger average square deviation) but also benefit significantly more from the treatments (larger reduction of the average % square deviation).
Figure 2 Remodelling of the
cholinergic transmission gene
networks.
In the set of experiments with t
re atments, the b et amet ha sone-primed (B) rats after the
first trigger of spasms (Y) were
randomized into treatment groups
treated either with full molecule of rat ACTH (BYA group),
PMX53 (BYP group) or Saline
(BYS group). (A) Part of the pathway regulated by the activation
of the cholinergic receptors of
the presynaptic and postsynaptic
neurons. M2/4: Muscarinic metabotropic acetylcholine receptors
( Chrm 2 / 4 ) ; Gi/o: G- proteins
(Gnai1/2/3, Gnao1, Gnb1/2/3/4/5,
Gng10/11/12/13/3/5/7/8); VCCC:
voltage-dependent calcium channels (Cacna1a/b); AC: adenylate
cyclases (Adcy2/3/4/5/7/8/9). (B–
E) Gene expression correlation in
the SNS (the absolute control: not
betamethasone-primed no spasms
pups treated with saline), BNS,
BYS, BYA and BYP conditions.

to the lack of statistical significance for ACTH and PMX53
effects in females. The microarray experiment confirmed
that both treatments (ACTH or PMX53) contributed to significant restoration of the synaptic pathway transcriptomes
and the relative effect was larger in males. In the 2018 treatment paper (Iacobaş et al., 2018a), the effect was evaluated
both by the reduction of percentage of regulated genes, and
by the recently introduced pathway restoration efficiency
(Iacobaş et al., 2018c). However, the same conclusion can
be drawn by using several other quantifiers. For instance,
as illustrated in Figure 1A and B by plotting the (log2) expression values in BYS, BYA and BYP conditions against
the corresponding values in BNS condition there were more
alterations but also more regenerations following the treat-

ments in males than in females. In Figure 1C we used the
average square deviation from the non-spasm value to evaluate alteration in animals with spasms treated with ACTH
(BYA), PMX53 (BYP) or just saline (BYS).
We have also obtained interesting results in the coordination analysis (Iacobaş and Iacobaş, 2010) of the synapse
genes in each of the five groups of rats (BYS, BYA, BYP,
BNS, SNS). In this analysis, two genes were considered as
synergistically expressed if the abundances of their transcripts increase or decrease simultaneously within biological replicas (the four animals of the group). The genes are
antagonistically expressed if their levels manifest opposite
tendencies and independently expressed if the variation of
one gene has no effect on the other’s level. Thus, we found
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that the transcriptomic networks by which the expressions
of genes synchronize to ensure the “transcriptomic stoichiometry” (Iacobaş et al., 2007) of the synaptic functional
pathways can be impaired by spasms and partially restored
by the anti-spasm treatments.
Figure 2 represents the transcriptomic network, by which
activated cholinergic receptors control the synaptic transmission in the arcuate nucleus of the male rat in each of the
five conditions. In Figure 2, a red/blue line indicates that the
connected genes are (P-value < 0.05) significantly synergistically/antagonistically expressed in that condition. Missing
connecting lines indicate not enough statistical evidence for
expression coordination. Of note is the substantial remodelling of the gene networks by prenatal exposure to betamethasone (compare BNS with SNS). Further, the seizure induction decoupled the cholinergic receptors from the G-proteins
in (BYS) and that the anti-spasms treatments (BYA and
BYP) restored most of this coupling. The results were similar for all neurotransmission types in both male and female
rats. This profound remodelling of the neurotransmission
genomic fabrics clearly shows how sensitive the synapse-mediated brain circuitries are to the neurological diseases and
treatments addressing these diseases.

Conclusions
The brain circuitry is continuously rebuilding (regenerating)
itself, responding with remodeling of the neurotransmission
transcriptome to the induced spasms and recovering in response to treatment of spasms. We determined that attenuation of neuroinflammation with PMX53 may become an
effective treatment approach for infantile spasms, which may
additionally improve comorbidity of infantile spasms with the
ASD. Using novel transcriptome analytical tools developed on
the genomic fabric paradigm (Iacobaş, 2016), we determined
that treatment efficacy (in both ACTH and PMX53) is associated with significant transcriptomic regeneration of synaptic
pathways and can inform about possible efficacy of treatments.
We also determined sex specificity of transcriptome changes
and recovery which adds another dimension to the developmental profile of changes after seizures (Azevedo et al., 2018).
Our novel tools improved quantification measures of both
alterations and recovery of the synaptic neurotransmission
transcriptome in the model of infantile spasms.
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